"AGT Selected to Work With Air Force Office of Scientific Research"
August, 2003.
AGT was awarded an STTR Phase I Contract from the Department of Defense to investigate the use of atmospheric plasma to neutralize biological warfare agents. Atmospheric plasma is well established as a feasible option for rapid and reliable neutralization of bioagents. AGT's end goal is to provide an optimized atmospheric plasma decon system with minimum power requirements.